Trial Profile
A Retrospective Cohort Study Assessing the Clinical Efficacy of Ivacaftor in Israeli Cystic Fibrosis Patients with the p.Ser549Arg (S549R) Mutation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Oct 2017
Price :
$35
*
At a glance
- Drugs Ivacaftor (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- 09 Oct 2017 New trial record
- 01 Oct 2017 Results published in the Respiratory Medicine Journal.